2m 2m 2m 2m 2m 2m 2m
ARMATA PHARMA (ARMP)
NYSE
$3.51+$0.19 (+5.89%)
Price as of Oct 02, 2026 4:15 PM EDT- $123.1MMarket Cap
- 7.86%1-Year Change
- BiotechnologyIndustry
ARMATA PHARMA (ARMP)
$3.51+$0.19 (+5.89%)
ARMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.31 | ||
Change | -$0.36 (-9.81%) | ||
Open | $3.67 | ||
High | $3.78 | ||
Low | $3.28 | ||
Previous Close | $3.67 | ||
Volume | 76,458 | ||
30-Day Average Volume | 349,014 | ||
1-Week Change | -8.56% | ||
1-Month Change | -37.31% | ||
1-Year Change | 7.86% | ||
3-Year Change | 10.33% | ||
5-Year Change | -8.56% | ||
Fundamentals | |||
Shares Outstanding | 37.2M | ||
Total Assets | $90.0M | ||
Market Cap | $123.1M | ||
Enterprise Value | $458.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $74.1M | ||
Free Cash Flow | -$8.7M | ||
EBIT | $74.1M | ||
EBITDA | $74.7M | ||
Net Working Capital | -$223.0M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/25/2017 | ||
Earnings & Revenue